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Low birth weight (LBW) continues to be a globally significant public health 
problem because of its short and long term effects on health. Many risk factors can 
cause LBW events. The nutritional factors that cause LBW, such as a low 
nutritional diet and inadequate weight gain during pregnancy, contribute to the low 
intake of nutrients that are important for fetal growth, such as vitamin B and iron. 
Ionic iron is a mineral that plays a role in the formation of new haemoglobin and is 
the main source of energy and oxygen transportation to the organs of the body. 
Decreased haemoglobin levels support changes in placental angiogenesis, limiting 
the availability of oxygen to the fetus and, consequently, potentially causing 
intrauterine growth retardation and low birth weight. This type of research is 
analytic with a case study research design with a cross-sectional approach, where 
factors are studied using a retrospective approach. This study is an analytic study 
to find out "The Relationship of Giving Tablets with Blood to Mothers with 0-59 
Months Infants to LBW in Mekarbakti Village, Sumedang Regency, West Java in 
2020". Based on the results of the study, the probability value (p-value) is greater 
than 0.005, meaning that there is a relationship of giving blood-added tablets to 
mothers who have babies aged 0-59 months to the blood in Mekarbakti village, 
Sumedang Regency, West Java in 2020. 




Low birth weight (LBW) continues to be a significant public health problem 
globally because of its short and long term effects on health. According to the 
World Health Organization (WHO), LBW is defined as birth weight less than 2500 
g [1;2]. In 2011, 15% of babies worldwide (more than 20 million people) were 
born with LBW and WHO estimates that there are around 25 million infants with 
LBW every year, and almost 95% of them are in developing countries [3]. The 
prevalence of low birth weight in developing countries (16.5%) is doubled 
compared to developed countries (7%) [4;5]. Asia has the lowest average birth 
weight in the world. Nearly a third of babies in the Southeast Asian region are born 
with low body weight [6]. Health problems that can arise in newborn LBW infants 
are hypothermia, hypoglycemia and impaired electrolyte and fluid balance, 
hyperbilirubinemia, infants more susceptible to infection, and respiratory 
problems, which can threaten the lives of babies. While the long-term problems 
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that can be caused are hearing loss, cognitive impairment and health problems 
when LBW babies have become adults namely hypertension, type 2 diabetes and 
heart disease [7]. 
In a study conducted in 2014 stated that LBW can be caused by several factors 
such as maternal factors (nutritional status, age, parity, economic status), history of 
poor pregnancy (having given birth to LBW, abortion), antenatal care poor care, 
fetal condition [8;9;10]. The results of the Sagung Adi Sresti Mahayana study 
showed evidence that one of the effects of anaemia on pregnant women gave birth 
to premature LBW infants (56.7%) [11;12]. Research conducted by Bharati, 
Bandyopadhyay, and others, in Nepal in 2018, the prevalence of low birth weight 
was 23.6% (with 95% CI 21.88 to 25.32%) of which almost all (95.45%) 
respondents received iron tablets and folic acid with 95% CI (94.60 to 96.30). 4 
Research conducted in 2016 at H. Boejasin Hospital, the proportion of LBW was 
20.2% of the total live births and the death rate was 17.3% where the death rate 
according to birth weight category was 96% in the <1000 g, 62% group in the 
1,000-1,499 g group, 19% in the 1,500-1,999 g group, and 4% in the 2,000-2,499 g 
group [9]. Babies born with low birth weight babies have a morbidity and mortality 
rate of 20-30 times higher than babies born with normal birth weight babies. LBW 
also causes a global infant mortality rate of more than 30% [13;14]. 
The prevalence of LBW per 100 births in the world reached 14.6% in 2015. This 
figure is lower than the prevalence of LBW in 2000, which is 17.5%. However, the 
highest incidence of LBW is still dominated by countries in Sub-Saharan Africa 
and Southeast Asia. The number of LBW infants in Southeast Asian countries 
reaches 9,807,400 babies [15;16] Indonesia, one of the countries in Southeast Asia, 
is still haunted by the LBW problem. The percentage of LBW babies in Indonesia 
according to the Indonesian Demographic and Health Survey is 7.1% of the birth 
rate of 17019 babies. In West Java, there is a percentage of LBW infants as much 
as 7.1% of the 3331 birth rates [17]. 
LBW is one of the Sustainable Development Goals (SDGs) targets that are 
included in the second sustainable development goal of eliminating hunger and all 
forms of malnutrition by 2030 and achieving food security. The target is set by 
reducing the LBW rate to 30% by 2025. This means a relative reduction of up to 
3% for each year between 2012 and 2025, and a reduction of around 20 million 
LBW infants to 14 LBW babies [18]. According to the National Reference Book 
for Maternal and Neonatal Health Services, LBW is a newborn whose birth weight 
is less than 2,500 grams (up to 2,499 grams). Concerning handling and life 
expectancy, low birth weight babies are distinguished as follows: a) Extremely low 
birth weight (ELBW), ie babies with birth weight < 1000 grams; b) Very low birth 
weight (VLBW), ie babies with birth weights < 1500 grams; and c) Low 
birthweight (LBW), ie babies with birth weights < 2500 grams [19;20]. 
Factors that can influence the birth weight of a baby are classified as follows: a) 
Internal environmental factors, which include maternal age, parietal, birth spacing, 
maternal health, maternal haemoglobin levels and anthropometric measurements of 
pregnant women; b) External environmental factors, which include environmental 
conditions, mother's food input during pregnancy, type of work the mother, mother 
and father's education level (head of a family), nutritional knowledge and 
socioeconomic level; DNA c) Health service use factors are frequency of antenatal 
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care (ANC) [21;22]. Many risk factors can cause LBW events, including maternal 
factors (maternal age, level of education, psychological stress, socioeconomic 
status, ANC, parity, pregnancy distance, nutritional status, nutritional intake, 
alcohol consumption, pregnancy diseases such as anaemia, preeclampsia), 
eclampsia, hypertension) and environmental factors (culture, highland residence, 
exposure to toxic substances) [23;24]. The nutritional factors that cause LBW, such 
as a low-nutrition diet and inadequate weight gain during pregnancy, contribute to 
the low intake of nutrients that are important for fetal growth, such as vitamin B 
and iron. 
Ionic iron is a mineral that plays a role in the formation of new haemoglobin and is 
a major source of energy and oxygen transportation to the organs of the body. 
Maternal anaemia can occur due to the unavailability of this element in the 
extracellular environment for erythropoiesis and the presence of an infection 
process, which can affect the metabolism of new haemoglobin. Decreased 
haemoglobin levels support changes in placental angiogenesis, limiting the 
availability of oxygen to the fetus and, consequently, potentially causing 
intrauterine growth retardation and low birth weight. Pregnant women with 
haemoglobin levels below 11 g/dL have a higher risk of having children with low 
birth weight compared to women who do not suffer from anaemia during 
pregnancy. Therefore, consumption of blood-added tablets has a very large impact 
on reducing the risk of maternal anaemia [25;26]. 
From the description above, the need for consumption of blood-added tablets 
during pregnancy to reduce LBW rates. For this reason, this study was conducted 
to determine the relationship between the history of supplementation of blood-
added tablets to mothers during gestational age with low birth weight (BLB) rates 
in toddlers aged 0-59 years in Mekarbakti Village, Sumedang Regency, West Java 
in 2020.  
 
2. METHOD 
This type of research is analytic with a case study research design with the cross-
sectional approach, where factors are studied using a retrospective approach. The 
location of this research is in Mekarbakti Village, Sumedang Regency, West Java 
in 2020 and carried out for 10 days. The population of this study is mothers who 
have babies aged 0-59 months and have low birth weight as many as 440 people. 
The sample used was 88 people. The instruments used in this study were: a) 
Stationery (pencils, pens, erasers, road boards); b) Maternal and Child Health Book 
(MCH); c) Inform Consent Sheet; d) Questionnaire Sheet; and e) SPSS. Data 
processing is carried out with a computerized system through several processes as 
follows: a) Editing, to ensure that the data obtained is complete or complete and 
can be read properly, relevantly, and consistently; b) Coding, can be obtained from 
data sources that have been checked for completeness then coding before 
processing with a computer; c) Data entry, encoded data processed with the help of 
a computer program; and d) Cleaning, the process of checking data back that has 
been entered if there are errors or errors. 
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3. RESULT AND DISCUSSION 
The variables studied that were described included the LBW incidence rate, and Fe 
supplementation included blood added tablets which included a history of giving 
blood added tablets, the number of blood added tablets obtained, the number of 
blood added tablets taken, the reason the mother did not consume all the added 
blood tablets obtained, the relationship between the number of tablets added blood 
obtained, the number of tablets added blood taken with the incidence of LBW in 
Mekarbakti Village, Sumedang, West Java in 2020. Univariate analysis is an 
analysis conducted to analyze each variable of research aimed at explaining and 
describing the characteristics of each variable. In this study, univariate analysis is a 
description of the characteristics of respondents and the variables studied and 
displayed in the form of frequency distribution tables and percentages (%). 
Table 1 Frequency Distribution of Infant Birth Weight Frequencies in 
Children 0-59 Months in Mekarbakti Village, Sumedang, West Java in 2020 
Description Frequency % 
LBW 7 8 
No LBW 81 92 
Total 88 100 
 
Table 1 above shows the number of samples that experienced LBW and did not 
experience LBW. From the above table, it is found that of 88 toddlers, there are 7 
toddlers (8%) born with LBW, and there are 81 toddlers (92%) who were not born 
with LBW in Mekarbakti village in 2020. Based on available data. 
Table 2 Historical Distribution of Fe Supplementation (Blood Added Tablets) 
during Pregnancy to Mothers with Toddlers Aged 0-59 Months in Mekarbakti 
Village, Sumedang, West Java in 2020 
Description Frequency % 
Yes 88 100 
No 0 0 
Total 88 100 
 
Table 2 above shows that of 88 respondents, all respondents (100%) received 
blood-added tablets during pregnancy. This shows that all mothers with children 
aged 0-59 months in Mekarbakti village in 2020 received blood-added tablets 
during pregnancy. 
Table 3. Frequency Distribution of the Amount of Fe Supplementation 
(Tablets Plus Blood) Obtained during Pregnancy for Mothers with Children 
Aged 0-59 Months in Mekarbakti Village, Sumedang, West Java in 2020 
Description Frequency % 
Get tablets to add less blood 7 8 
Get tablets to add enough blood 81 92 
Total 88 100 
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Table 3 above shows that of the 88 respondents, the majority of respondents with 
81 respondents (92%) received an adequate amount of Fe supplementation (tablets 
plus blood). The amount of blood added tablets obtained is quite as much as more 
than 90 tablets added blood, whereas 7 respondents (8%) get less amount of Fe 
supplementation (tablets plus blood). The number of tablets plus blood obtained is 
less the same as less than 90 tablets added with blood. 
Table 4 Frequency Distribution of the Total Consumption of Fe 
Supplementation (Tablets Plus Blood) Obtained during Pregnancy in Mothers 
with Toddlers Aged 0-59 Months in Mekarbakti Village, Sumedang, West 
Java in 2020 
Description Frequency % 
Get tablets to add less blood 10 11,4 
Get tablets to add enough blood  78 79,6 
Total 88 100 
 
Table 4 above shows that of the 88 respondents, the majority of respondents with 
78 respondents (79.6%) consumed a sufficient amount of Fe supplementation 
(tablets plus blood). The number of tablets plus blood consumed is enough as 
much as more than 90 tablets added blood. Whereas 10 respondents (11.4%) 
consume less amount of Fe supplementation (tablets plus blood). The number of 
blood-added tablets consumed is less than the amount of less than 90 blood-added 
tablets. 
Table 5. Frequency distribution of reasons for supplementation of Fe (Tablets 
Plus Blood) not Consumed during Pregnancy in Mothers with Toddlers Aged 
0-59 Months in Mekarbakti Village, Sumedang, West Java in 2020 
Reason Frequency % 
Bored 3 3,4 
Side effects (nausea / constipation) 1 1,1 
Forget 8 9,1 
Nauseous vomit 12 13,6 
Not Yet Time Out 0 0 
Do not like 1 1,1 
Total 25 28,4 
 
Table 5 above shows that of the 88 respondents, the majority of respondents with 
63 (71.6%) respondents consumed the amount of Fe supplementation (tablets plus 
blood) according to the amount obtained [36]. Whereas 25 respondents (28.4%) 
consume less blood added tablets than the number of added blood tablets. Three 
respondents (3.4%) did not routinely consume blood-added tablets because they 
were bored. One respondent (1.1%) did not routinely consume blood-added tablets 
because of the side effect of nausea. Eight respondents (9.1%) did not routinely 
consume blood tablets because they forgot. Twelve respondents (13.6%) did not 
routinely consume blood tablets because of nausea/vomiting. One respondent 
(1.1%) did not routinely consume blood-added tablets because he did not like it. 
Bivariate analysis was carried out to see the relationship between the independent 
variable (Fe supplementation ie the number of tablets added to blood obtained and 
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the number of tablets added to blood taken) with the dependent variable (LBW 
events). The statistical test used was the Chi-Square test with a degree of 
confidence of 95% (α = 0.05). The provisions of the Chi-Square test according to 
Hastono and Sabri (2010) are as follows: a) The Chi-Square test is very well used 
for tables with large degrees of freedom (df); b) If the table used is 2x2 and no 
cells have Expected Count (E) <5, then the test used should be Continuity 
Correction; c) If the 2x2 table is found cells have an E value <5, then the test used 
is the Fisher Exact Test, and if the table is more than 2x2 using Pearson Chi-
Square; and d) Decisions made from the Chi-Square results are if p> α (0.05), Ho 
is rejected.  
Table 6 Relationship of Giving Tablets Added to Blood Drunk by LBW 
Incidence Rate 
The category of Tablets 
Add blood 










N % N % N % 
 
 
Giving tablets added less 
blood 
5 5,7 5 5,7 10 11,4 
0,000 2,714 
Giving tablets added 
enough blood 
2 2,3 76 86,4 78 88,6 




Table 6 above shows that from 8 mothers who consumed less blood added tablets, 
there was 1 toddler who experienced LBW and 7 toddlers who did not have LBW. 
Meanwhile, of the 80 mothers who consumed enough added blood tablets, 4 
toddlers experienced LBW and 76 toddlers who did not have LBW. Thus it is 
known that toddlers who did not experience the most LBW events in mothers who 
consumed enough blood added tablets as many as 76 people. Whereas toddlers 
who experienced the most LBW occurrence in mothers who consumed less added 
blood tablets were 4 toddlers. P-value 0,000 indicates that the p-value <α, where α 
value is 0.005. So there is a significant difference between the number of tablets 
added blood consumed with LBW events, and the relationship between the number 
of tablets added blood consumed with LBW events. The OR value is indicated by 
the "estimate" value of 2.714, meaning that mothers who get blood-added tablets 
tend to have a 2.7-fold risk of giving birth to infants with LBW events compared to 
those who get enough blood-added tablets. 
Based on available data, it was found that out of 88 toddlers, 7 toddlers (8%) were 
born with LBW, and there were 81 toddlers (92%) who were not born with LBW 
in Mekarbakti village in 2020. This is comparable to Ayesha Khan's research, 
involving 947 single live births at term stated during the study period that a small 
percentage (10.6%) of patients delivered LBW infants [27;28]. Data obtained from 
this study show that all mothers with children aged 0-59 months in Mekarbakti 
village in 2020 received blood-added tablets during pregnancy. This is in line with 
Tumaji's research in 2014, which stated that as many as 85% of pregnant women in 
urban slums in West Java Province and as many as 96% of pregnant women in 
urban slums in DIY received iron tablets when checking their pregnancy in health 
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workers. The percentage shows that the coverage of iron tablets in the province has 
exceeded the minimum percentage set by the government [29;30]. Data obtained 
during the study showed that almost the majority (81 respondents) received 
sufficient amounts of Fe supplementation (tablets plus blood). The number of 
tablets added with blood that is enough is more than equal to 90 tablets added with 
blood [31;32].  
Our research data found that 78 respondents (79.6%) consumed an adequate 
amount of Fe supplementation (tablets plus blood). The number of tablets plus 
blood consumed is enough as much as more than 90 tablets added blood [33]. The 
number of tablets plus blood obtained is less the same as less than 90 tablets added 
with blood. This study is not comparable with the Iryani K study that the number 
of consumption of Fe tablets < 90 tablets during pregnancy in the case group was 
44 people (37.9%) more than the riskless pregnancy (consumption of Fe tablets ≥ 
90 tablets during pregnancy) as many as 14 people ( 12.1%) [34;35]. From the 
research data, we found there were 25 respondents (28.4%) consuming less blood 
added tablets than the number of added blood tablets. Three respondents (3.4%) 
did not routinely consume blood-added tablets because they were bored. One 
respondent (1.1%) did not routinely consume blood-added tablets because of the 
side effect of nausea, eight respondents (9.1%) did not routinely take blood-added 
tablets because they forgot. Twelve respondents (13.6%) did not routinely 
consume blood tablets because of nausea/vomiting. One respondent (1.1%) did not 
routinely consume blood-added tablets because he did not like it. This is not 
following the results of the previous Ratna Juwita study which showed that 
pregnant women who were not compliant to consume Fe tablets were 37 mothers 
(82.2%). Based on a questionnaire distributed to respondents of non-compliance 
with pregnant women consuming Fe tablets including nausea/vomiting due to 
pregnancy which was 85.7%, because of the side effects of Fe tablets as much as 
70% some respondents took Fe tablets if they felt unwell and stopped if they felt 
well which is 42.8%. But in general, the respondents stated that the Fe tablets were 
very good at 91.4%, and felt better and healthier by taking 75.7% Fe tablets 
[36;37]. 
The relationship between the history of iron supplementation with LBW events (p 
= 0,000, OR = 2,714) where the value of P> α indicates a relationship between the 
number of tablets added with blood obtained with LBW events. Ika Saptarini's 
research results, in 2015, about factors related to the consumption of iron tablets in 
pregnant women, iron tablets in pregnant women can be obtained every time they 
do antenatal care or pregnancy checks. A qualitative study in West Java found that 
some mothers did receive iron tablets every ANC visit, but because the amount 
received varied (15 tablets to 30 tablets), not all mothers received a total of at least 
90 iron tablets during pregnancy. Where ANC visits as recommended (K4) did not 
show an association with the number of iron tablets consumed by pregnant women 
during pregnancy. This is also possible because the iron tablets obtained during the 
visit are indeed inadequate. The results of the qualitative study also found that 
some respondents received a large number of tablets varying between 7-15 tablets 
per visit, as well as according to the midwife public health centre. This is because 
the supply of iron tablets in the public health centre is often limited [38;39]. The 
results of the Demographic and Health Survey (Demographic Health Survey) in 
several countries in 2004-2007 also showed that 20-60% of mothers with ANC 
visits 3 times or more received less than 90 iron tablets [41]. Sulistianingsih A's 
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research, in 2017, showed that the lowest number of Fe tablets consumed by 
pregnant women who consumed iron tablets during the day was 37 people. If Fe 
tablets are given according to antenatal care service standards ie 90 tablets during 
pregnancy and good diet it will have a significant influence on the Hb status of 
pregnant women [42]. 
The need for Fe during pregnancy is approximately 1000 mg, of which 500 mg is 
needed to increase the mass of red blood cells, 300 mg for transportation to the 
fetus in a 12-week pregnancy and 200 mg again to replace the fluid that comes out 
of the body. The need for Fe during the first trimester is relatively slightly around 
0.8 mg a day which then increases sharply during the second and third trimesters, 
which is 6.3 mg a day. This is because during pregnancy there is a progressive 
increase in blood volume from the 6th to the 8th week of pregnancy and reaches a 
peak in the 32nd to 34th week with minor changes after that week. 
Supplementation of Fe tablets is one of the most effective iron deficiency anaemia 
prevention and management programs that can increase haemoglobin levels in 
pregnant women and can reduce the prevalence of anaemia in pregnant women by 
20-25%. Fe tablets contain 200 mg of ferrous sulfate and 0.25 mg of folic acid 
which is bound with lactose. Pregnant women are advised to consume Fe tablets of 
at least 90 tablets at a dose of 1 tablet per day in a row for 90 days of pregnancy 
[43]. 
In this study also obtained P 0,000 with an OR value of 2.714 which shows the 
relationship between the number of tablets added by blood consumed with LBW 
events. In this study, only a few mothers had babies with LBW but OR was 
declared significant, although only 8 toddlers were born with LBW of 88 toddlers 
in Mekarbakti village, Sumedang Regency, West Java Province. This study is in 
line with Pratiwi A's research, in 2018 about the relationship of anaemia in 
pregnant women with LBW events, which showed that the relationship between Fe 
tablets and LBW events did not have a meaningful value, indicated by the value of 
p = 0.1 and the OR value obtained was 0.52 which can be interpreted that giving 
Fe tablets to pregnant women is a factor that reduces the occurrence of LBW [44]. 
The Fatimatasari study, in 2013, regarding compliance with consuming Fe tablets 
during pregnancy, was related to the incidence of Low Birth Weight Babies 
(LBW), which showed that there was a relationship between the level of adherence 
to consuming Fe tablets during pregnancy with the incidence of low birthweight 
babies (LBW). There was 46.7 per cent of respondents claimed to consume iron 
tablets as recommended (a minimum of 90 tablets during pregnancy) [44]. Wiwit 
H's research, in 2012, about the relationship of compliance of pregnant women 
consuming Fe tablets with anaemia, showed that pregnant women who were 
obedient in consuming Fe tablets were more (50.9%) than those who were not 
(49.1%) [39].  
The results of the above study support the theory that pregnant women need more 
iron than non-pregnant women so they have to get additional iron supplements. 
Iron tablets are associated with an increase in haemoglobin levels in the blood 
which functions to bind and distribute oxygen to body cells, including fetal tissue 
cells. If the Hb level is < 11gr%, this means that it shows anaemia during 
pregnancy, then the distribution of oxygen to the tissue will be reduced so that 
tissue metabolism decreases, including in the fetus, so growth will be stunted and 
result in low infant weight [45].  
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From the 88 respondents, after a statistical test, a P value of 0,000 was obtained 
which indicates a relationship between the number of tablets added with blood 
obtained with LBW events. The need for Fe during pregnancy is approximately 
1000 mg, of which 500 mg is needed to increase the mass of red blood cells, 300 
mg for transportation to the fetus in a 12-week pregnancy and 200 mg again to 
replace the fluid that comes out of the body. The need for Fe during the first 
trimester is relatively slightly around 0.8 mg a day which then increases sharply 
during the second and third trimesters, which is 6.3 mg a day. This is because 
during pregnancy there is a progressive increase in blood volume from the 6th to 
the 8th week of pregnancy and reaches a peak in the 32nd to 34th week with minor 
changes after that week. Supplementation of Fe tablets is one of the most effective 
iron deficiency anaemia prevention and management programs that can increase 
haemoglobin levels in pregnant women and can reduce the prevalence of anaemia 
in pregnant women by 20-25%. Fe tablets contain 200 mg of ferrous sulfate and 
0.25 mg of folic acid which is bound with lactose. Pregnant women are advised to 
consume Fe tablets of at least 90 tablets at a dose of 1 tablet per day in a row for 90 
days of pregnancy [25]. 
In this study also obtained a P-value of 0,000 with an OR value of 2.714 which 
indicates a relationship that has a meaningful value between the number of tablets 
added by blood consumed with LBW events. This study is in line with the 2018 
Pratiwi A study about the relationship of anaemia in pregnant women with LBW 
events, which shows that the relationship between Fe tablets and LBW events has a 
significant value, indicated by the value of p = 0,000 and the OR value obtained is 
2.714 which can be interpreted that giving Fe tablets to pregnant women is a factor 
that reduces the occurrence of LBW. In this study, only a few mothers had babies 
with LBW, so the OR was declared insignificant, only 8 toddlers born with LBW 
of 88 toddlers in Mekarbakti village, Sumedang Regency, West Java Province. The 
Fatimatasari study, in 2013, regarding compliance with consuming Fe tablets 
during pregnancy, was related to the incidence of Low Birth Weight Babies 
(LBW), which showed that there was a relationship between the level of adherence 
to consuming Fe tablets during pregnancy with the incidence of low birthweight 
babies (LBW). There is 46.7 per cent of respondents claimed to consume iron 
tablets as recommended (a minimum of 90 tablets during pregnancy). Ika Saptarini 
research results, in 2015, about factors related to consumption of iron tablets in 
pregnant women, from 66 cases and 66 controls showed that 46.7 per cent of 
respondents claimed to consume iron tablets as recommended (at least 90 tablets 
during pregnancy) and 53, 3% of respondents consume iron tablets poorly during 
pregnancy [41]. 
The results of the above study are similar to the theory which says that pregnant 
women need more iron than women who are not pregnant so they must get an 
additional form of iron supplements. Iron tablets are associated with an increase in 
haemoglobin levels in the blood which functions to bind and distribute oxygen to 
body cells, including fetal tissue cells. If the Hb level <11gr%, this means anaemia 
during pregnancy, then the distribution of oxygen to the tissue will be reduced so 
that tissue metabolism decreases, including the fetus, growth will be stunted and 
result in low infant weight [46;47]. 
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Based on the results of research and discussion in the previous chapter, the 
following conclusions can be drawn: a) Of 88 respondents, including 7 toddlers 
with LBW (8%); b) All respondents received Fe supplementation during 
pregnancy (100%); c) Of the 88 respondents, there were 81 respondents receiving 
iron supplementation of > 90 items during pregnancy (92%); c) Of 88 respondents, 
there were 78 respondents (79.6%) consuming an adequate amount of Fe 
supplementation (tablets plus blood); d) Respondents did not consume Fe 
supplementation due to nausea/vomiting (13.2%); and e) There is a significant 
relationship between Fe supplementation for mothers with infants aged 0-59 
months and LBW in Mekarbakti Village, Sumedang Regency in 2020. 
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